Serious adverse events associated with yellow fever 17DD vaccine in Brazil: A report of two cases

Lancet

Volumn 358, Issue 9276, 2001, Pages 91-97

  Vasconcelos, Pedro F C ^a   Luna, Expedito J ^l   Galler, Ricardo ^d   Silva, Luiz J ^c   Coimbra, Terezinha L ^b   Barros, Vera L R S ^a   Monath, Thomas P ^h   Rodigues, Sueli G ^a   Laval, Cristina ^f   Costa, Zouraide G ^e   Vilela, Maria F G ^l   Santos, Cecília L S ^b   Papaiordanou, Cristina M O ^c   Alves, Venancio A F ^b   Andrade, Liliana D ^c   Sato, Helena K ^g   Rosa, Elisabeth S T ^a   Froguas, Gustavo B ^j   Lacava, Ethel ^e,i   Almeida, Leda M R ⁱ   Cruz, Ana C R ^a   Rocco, Iray M ^b   Santos, Raimunda T M ^b   Oliva, Otávio F P ^k   more..

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

^b Instituto Adolfo Luz   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e CENEPI/FUNASA   (Brazil)

^f Enfermeira da Estratégia de Saúde da Família   (Brazil)

^g Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^h Acambis   (United States)

ⁱ Setor de Vigilância Epidemiológica e Zoonoses   (Brazil)

^j Secretaria Municipal de Saúde   (Brazil)

^k PAN AMERICAN HEALTH ORGANIZATION   (United States)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VIRUS RNA; YELLOW FEVER 17DD VACCINE; YELLOW FEVER VACCINE;

ADULT; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING TENDENCY; BLOOD CELL; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DRUG SAFETY; FEMALE; GENE SEQUENCE; HEMORRHAGIC FEVER; HISTOPATHOLOGY; HUMAN; JAUNDICE; KIDNEY FAILURE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE; TISSUE INJURY; TISSUE SLICE; VACCINATION; VIRUS CHARACTERIZATION; VIRUS GENE; YELLOW FEVER FLAVIVIRUS;

EID: 0035859498     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05326-0     Document Type: Article

References (22)

1. Yellow fever: A decade of reemergence
2. An epidemic of sylvatic yellow fever in the southeast region of Maranhao State, Brazil, 1993-1994: Epidemiologic and entomologic findings
3. Yellow fever in Pará State, Amazon Region of Brazil, 1998-1999: Entomologic and epidemiologic findings
4. An epidemic of jungle yellow fever in Brazil, 2000: Implications of climatic alterations in the disease spread
5. Aedes aegypti, dengue and re-urbanization of yellow fever in Brazil and other South American Countries: Past and present situation and future perspectives
6. Dengue epidemic in Belém, Pará, Brazil, 1996-97
7. Yellow Fever
8. Use of yellow fever modified by in vitro cultivation for human immunization
9. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses
10. The use of a microhemagglutination-inhibition test to follow antibody response after arthropod-borne virus infection in a community of forest animals
11. Detecting artificial antidengue IgM immune complexes using an enzyme-linked immunosorbent assay
12. Arboviruses
13. Complete nucleotide sequence of the genome from yellow fever virus 17DD and 17D-213 vaccine strains
14. Genetic variation in yellow fever virus: Duplication in the 3′ noncoding regions of strains from Africa
15. A method for the isolation and identification of dengue viruses, using mosquito cell cultures
16. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies
17. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis
18. The virus
19. Requirements for yellow fever vaccine
20. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis
21. Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1